Controlled Inflammation Drives Neutrophil‐Mediated Precision Drug Delivery in Heterogeneous Tumors

Controlled Inflammation Drives Neutrophil‐Mediated Precision Drug Delivery in Heterogeneous Tumors

Abstract Tumor heterogeneity remains a formidable obstacle in targeted cancer therapy, often leading to suboptimal treatment outcomes. This study presents an innovative approach that harnesses controlled inflammation to guide neutrophil‐mediated drug delivery, effectively overcoming the limitations...

Full description

Saved in:
Bibliographic Details
Main Authors: Yunfei Guo, Yiming Li, Jianmin Li, Haoran Cai, Kangkang Liu, Dengyi Duan, Wenyi Zhang, Gang Han, Yang Zhao
Format: Article
Language:English
Published: Wiley 2025-03-01
Series:Advanced Science
Subjects:
inflammation
nanomedicine
Neutrophil
tumor targeted therapy
Online Access:https://doi.org/10.1002/advs.202411307
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/advs.202411307

Similar Items